生命的化学2023,Vol.43Issue(12) :1907-1913.DOI:10.13488/j.smhx.20230486

慢性肾脏病肾小管损伤诊断标志物的研究进展

Research progress on diagnostic biomarkers for renal tubular injury in chronic kidney disease

何望 周恩超 葛宏伟 张凯钰
生命的化学2023,Vol.43Issue(12) :1907-1913.DOI:10.13488/j.smhx.20230486

慢性肾脏病肾小管损伤诊断标志物的研究进展

Research progress on diagnostic biomarkers for renal tubular injury in chronic kidney disease

何望 1周恩超 2葛宏伟 1张凯钰1
扫码查看

作者信息

  • 1. 南京中医药大学附属医院,南京 210029
  • 2. 江苏省中医院,南京 210029
  • 折叠

摘要

肾小管萎缩和肾小管间质纤维化是慢性肾脏疾病(chronic kidney disease,CKD)常见的病理表现,肾小管损伤的生物标志物通常可反映肾小管间质中直接组织损伤和修复的过程,其严重程度一直被证明是预测疾病进展的可靠指征.目前大部分研究常利用肾小球滤过率和尿白蛋白/肌酐比作为评估CKD的主要指标,而肾小管损伤诊断标志物在慢性肾脏病中的研究较少.因此,本文就肾小管损伤诊断标志物在CKD中的研究进展作一综述,以期最大限度地诊断、治疗和预防CKD,对肾脏健康进行更加全面的评估.

Abstract

Renal tubular atrophy and tubulointerstitial fibrosis are common pathologic manifestations of chronic kidney disease(CKD).Biomarkers of renal tubular injury usually reflect the process of direct tissue injury and repair in the renal tubular interstitium,and their severity has been shown to be a reliable indication for predicting disease progression.Most studies use glomerular filtration rate and urine albumin/creatinine ratio as the main indicators for assessing CKD.However,diagnostic markers of renal tubular injury have not been studied clearly in chronic kidney disease.Therefore,this paper provides the research progress of renal tubular injury diagnostic markers in CKD,with the aim of maximizing the diagnosis,treatment and prevention of CKD and providing more comprehensive assessment of kidney health.

关键词

慢性肾脏病/肾小管损伤/生物标志物

Key words

chronic kidney disease/renal tubular injury/biomarkers

引用本文复制引用

基金项目

南京市科技局医疗卫生国际联合研发项目(202002051)

南京中医药大学中医学优势学科三期项目(ZYX03KF076)

出版年

2023
生命的化学
中国生物化学与分子生物学会

生命的化学

CSTPCD
影响因子:0.404
ISSN:1000-1336
参考文献量3
段落导航相关论文